| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.092 | 0.09 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.09 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |